Stablepoint Partners’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.91M Sell
4,813
-368
-7% -$161K 0.26% 109
2026
Q1
$2.39M Sell
5,181
-16
-0.3% -$8.1K 0.36% 86
2025
Q4
$2.94M Buy
5,197
+25
+0.5% +$13.3K 0.46% 70
2025
Q3
$2.31M Buy
5,172
+234
+5% +$112K 0.37% 86
2025
Q2
$2.68M Buy
4,938
+74
+2% +$38.7K 0.46% 71
2025
Q1
$2.41M Sell
4,864
-191
-4% -$106K 0.44% 73
2024
Q4
$2.64M Sell
5,055
-50
-1% -$26K 0.48% 64
2024
Q3
$2.51M Sell
5,105
-151
-3% -$70.3K 0.46% 69
2024
Q2
$2.33M Buy
5,256
+146
+3% +$58.1K 0.45% 68
2024
Q1
$2.04M Buy
5,110
+676
+15% +$255K 0.41% 75
2023
Q4
$1.5M Buy
+4,434
New +$1.32M 0.38% 76

Other funds holding ISRG

Stablepoint Partners's ISRG Position: Q2 2026 in Review

Stablepoint Partners reduced its Intuitive Surgical (ISRG) stake by 7.1% in Q2 2026, selling an estimated $161K and leaving 4,813 shares worth $1.91M. The position accounts for 0.26% of the portfolio, ranked #109.

Stablepoint Partners first reported a position in ISRG in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.94M in Q4 2025. 636 funds tracked by Wall St. Rank hold ISRG as of Q2 2026.

  • Stablepoint Partners held 4,813 shares of Intuitive Surgical worth $1.91M as of Q2 2026.
  • Stablepoint Partners sold 368 Intuitive Surgical shares in Q2 2026, an estimated $161K.
  • Intuitive Surgical made up 0.26% of Stablepoint Partners's portfolio in Q2 2026, its #109 holding.
  • Stablepoint Partners first reported a position in Intuitive Surgical in Q4 2023 and has held it in 11 quarters since.
  • Stablepoint Partners's Intuitive Surgical position peaked at $2.94M in Q4 2025.
  • 636 funds tracked by Wall St. Rank held Intuitive Surgical as of Q2 2026.

Based on Stablepoint Partners's 13F filing for Q2 2026, filed 9 Jul 2026.